DAX24.301 +0,1%ESt505.342 -0,3%Top 10 Crypto16,56 +4,5%Dow44.574 +0,5%Nas21.046 +0,7%Bitcoin101.229 +0,4%Euro1,1709 +0,6%Öl68,94 -0,4%Gold3.397 +1,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 DroneShield A2DMAA Lufthansa 823212 Novo Nordisk A3EU6F BYD A0M4W9 EVOTEC 566480 Clara Technologies A3E4MS thyssenkrupp 750000 Tesla A1CX3T BASF BASF11 HENSOLDT HAG000 Deutsche Telekom 555750 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Vor Zoll-Ultimatum: DAX stabil -- Wall Street fester -- EVOTEC senkt Umsatzprognose -- Rheinmetall schafft neue Jobs -- Plug Power, Ryanair, Merck, Opendoor, Novo Nordisk, Volatus im Fokus
Top News
Bitcoin, Dogecoin, Ethereum & Co. am Nachmittag Bitcoin, Dogecoin, Ethereum & Co. am Nachmittag
Stocks in Action USA: Verizon Communications, Block, Cleveland-Cliffs Stocks in Action USA: Verizon Communications, Block, Cleveland-Cliffs
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

SOPHiA GENETICS SA Aktie

Handeln
Aktien-Sparplan anlegen
3,22 EUR +0,04 EUR +1,26 %
FSE
3,58 USD -0,14 USD -3,76 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.213,55 Mio. EUR

WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA3CVT8

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINCH1125843347

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolSOPH

SOPHiA GENETICS SA Aktien News

DatumMeistgelesen
ZacksSOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates
PR NewswireSOPHiA GENETICS Reports First Quarter 2025 Results
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
Wer­bungSOPHiA GENETICS SA-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025
PR NewswirePrecision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities
PR NewswirePrecision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities
PR NewswireSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
PR NewswireSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
PR NewswireSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
PR NewswireSOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
ZacksSOPHiA GENETICS SA (SOPH) Reports Q4 Loss, Tops Revenue Estimates
PR NewswireSOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025
PR NewswireSOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
PR NewswireSOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
PR NewswireSOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
PR NewswireSOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
PR NewswireSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
PR NewswireSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
PR NewswireSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
PR NewswireSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
PR NewswireSOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer
PR NewswireSOPHiA GENETICS Reports Third Quarter 2024 Results
PR NewswireSOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024
PR NewswireSOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
PR NewswireSOPHiA GENETICS Announces Poster Presentations at ESMO 2024
PR NewswireSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
PR NewswireSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
PR NewswireSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
PR NewswireSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

SOPHiA GENETICS SA News

SOPHiA GENETICS SA News: auf dieser Seite finden Sie alle SOPHiA GENETICS SA News und Nachrichten zur SOPHiA GENETICS SA Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch SOPHiA GENETICS SA News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um SOPHiA GENETICS SA News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.